Blossomhill Therapeutics (BLSM US)

Analysis

Health Care • United States

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. The Company develops small molecule medicines that address unmet medical needs in cancer treatment. Blossomhill Therapeutics operates in the United States.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00